Form 4: Lam Research CFO Exercises Options, Sells Shares

Lam Research's CFO, Douglas R. Bettinger, exercised stock options and subsequently sold a portion of the acquired common stock on March 4, 2026, as part of a pre-arranged plan.

Summary

• Douglas R. Bettinger, Chief Financial Officer & EVP of Lam Research Corp (LRCX), reported transactions on March 4, 2026.
• Bettinger exercised employee stock options to acquire 51,270 shares of common stock at an exercise price of $49.092 per share.
• Additionally, Bettinger exercised employee stock options to acquire 26,480 shares of common stock at an exercise price of $98.153 per share.
• Following these acquisitions, Bettinger sold 50,057 shares of common stock at a weighted average sale price of $224.03 per share, with individual sales ranging from $223.90 to $224.39.
• After these transactions, Bettinger's direct beneficial ownership of common stock stands at 1,081,705 shares, which includes shares subject to unvested restricted stock units.
• The transactions were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine insider transaction, where the CFO exercised long-held options and sold a portion of the resulting shares, likely for diversification or tax purposes under a pre-arranged 10b5-1 plan. The exercise of options at significantly lower prices highlights past stock performance.

Positives

• The exercise of stock options at significantly lower prices ($49.092 and $98.153) compared to the sale price ($224.03) indicates substantial past value creation for the executive.
• The transaction was executed under a Rule 10b5-1 plan, suggesting a pre-planned and systematic approach to managing personal finances rather than a reaction to new, non-public information.

Negatives

• The sale of 50,057 shares by a key executive, even if pre-planned, represents a reduction in direct equity exposure to the company.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that such transactions are common for executives, often executed under Rule 10b5-1 plans to manage personal finances and diversify holdings without implying a specific market outlook. This is a standard practice in the semiconductor equipment industry for executive compensation, allowing executives to realize value from their equity awards.

Stakeholder Impact

• Shareholders may interpret the sale of shares by a key executive as a signal, though the context of a 10b5-1 plan suggests it is part of routine financial planning and diversification rather than a reaction to new company-specific information.

Next Steps

• The remaining 13,240 employee stock options (with an exercise price of $98.153) will become exercisable in their final installment on March 1, 2027.

Key Dates

Recommendation

The transaction represents a standard executive compensation event involving option exercise and subsequent sale, likely under a 10b5-1 plan. While the sale of shares by a CFO can sometimes be viewed negatively, the context of option exercise and the potential for diversification or tax planning suggests it does not fundamentally alter the investment thesis for Lam Research. Therefore, a 'hold' recommendation is appropriate, pending further operational or strategic updates.

Keywords

Lam Research, LRCX, Insider Trading, Form 4, Stock Options, Executive Compensation, CFO, Share Sale, 10b5-1 Plan